Sort
82,697 grants matching “vaccine development”
Preclinical Studies and Mucosal Responses
$1,283,173Rama Rao Amara · Geovax, Inc. · U19 · FY2010 · AI
Enhancing immunity to malaria in young children with effective chemoprevention
$1,283,030Prasanna Jagannathan · Stanford University · U01 · FY2021 · AI
Vaccine and Treatment Evaluation Units
$1,282,926Nadine Georges Rouphael · Emory University · UM1 · FY2025 · AI
Examination of Enteric Pathogens with Multi-Omic Approaches
$1,282,796David A Rasko · University Of Maryland Baltimore · U19 · FY2014 · AI
Rift Valley Fever Vaccine Development of Animal Models and Optimize Production
$1,282,621Clarence J. Peters · University Of Texas Med Br Galveston · U01 · FY2009 · AI
T Cell Immune Responses To HIV And Other Pathogens
$1,282,212Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Testing of Blood Samples for Immune Response and Vaccine Research
$1,282,211Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Clinical Trials of Biodefense Vaccines (Dengue)
$1,282,189Stephen Whitehead · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,281,901Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Cancer Biomaterials Engineering
$1,281,899Matthew Wolf · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Strategies for inducing bnAbs against QNES by infection with SHIVs
$1,281,787Shiu-Lok Hu · Rbhs-New Jersey Medical School · P01 · FY2013 · AI
Enhancing B cell immunity against HIV-1 using novel vaccine delivery platforms
$1,281,293Michael W Cho · Iowa State University · U19 · FY2013 · AI
Project 2: Current Good Manufacture Practices (CGMP) Production of Nucleoside-Modified mRNAs Encoding HIV-1 Envelopes
$1,280,922Frederick Porter · Duke University · U19 · FY2021 · AI
A SIMPLE AND COST EFFECTIVE CERVICAL CANCER VACCINE
$1,280,858Frank Bedu-Addo · Pds Biotechnology Corporation · N44 · FY2009 · CA
Vaccine Induced Immunity in the Young and Aged
$1,280,745Rafi Ahmed · Emory University · U19 · FY2009 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,280,579Stanley Perlman · University Of Iowa · P01 · FY2017 · AI
Improving the efficacy of anti-nicotine immunotherapy
$1,280,461Alexey G Mukhin · Duke University · RC2 · FY2010 · DA
Experimental characterization of the dynamics of immune responses to influenza
$1,280,261Rafi Ahmed · Emory University · U19 · FY2018 · AI
Assessment of vaccine/microbicide combination efficacy in the macaque model
$1,280,247Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R01 · FY2009 · AI
Advanced Development of Vaccines for Influenza
$1,280,042Uwe Staerz · Greffex, Inc. · N01 · FY2022 · AI
Expanded SPF Rhesus Macaque Breeding Colony for AIDS Research
$1,279,656Michael K Axthelm · Oregon Health & Science University · U42 · FY2016 · OD
Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1
$1,279,617Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U01 · FY2020 · AI
Vaccines and Therapeutics for Anthrax
$1,279,553Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Technologies to Advance Next Generation Anthrax Vaccines
$1,279,550Vidadi Yusibov · Center For Expermental Software Engr Md · N01 · FY2015 · AI
SPORE in Cervical Cancer
$1,279,343T.-C. Wu · Johns Hopkins University · P50 · FY2019 · CA